We recently published a list of Traders Heavily Sold Down These 10 Stocks on Thursday. In this article, we are going to take ...

The showdown between the Trump administration and Harvard University is spotlighting bare-knuckled politics and big dollar ...

In a high-stakes standoff, President Donald Trump’s administration says it will freeze $2.2 billion in federal research ...

Charles River Associates CRAI has performed extremely well over the past year and has the potential to sustain the momentum in the near term. Consequently, you should add the stock to your portfolio ...

Charles River Labs faces a 60% loss due to reduced R&D spending, FDA's phase-out of animal testing, and increased competition ...

Shares of Charles River Labs (CRL) crashed 28% after the U.S. FDA (Food and Drug Administration) announced plans to phase out the need for ...

Barclays lowered the firm’s price target on Charles River (CRL) to $145 from $160 and keeps an Equal Weight rating on the shares as part of a ...

One of the most promising aspects of AI and its integration into the pharmaceutical industry is the technology’s potential to ...

First Logica-identified candidate marks a progression-based milestone in ongoing partnership with Pioneering Medicines, Flagship Pioneering’s in-house drug development unit Charles River ...

The drug discovery pact between Charles River Laboratories, Valo Health and Flagship Pioneering is starting to bear fruit. Charles River and Valo’s molecule designing platform has yielded its ...

Would the thought of a floating garden among walkways along the Fox River in St. Charles spark a little more interest in the river? What if we said such a concept could unfold regardless of what ...